FDA Recommends Monovalent XBB.1.5 Vaccine for Fall 2023
Based on the current and expected evolution of SARS-CoV-2, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) is advising vaccine manufacturers to update
Based on the current and expected evolution of SARS-CoV-2, the FDA Vaccines and Related Biological Products Advisory Committee (VRBPAC) is advising vaccine manufacturers to update